LDLT or DDLT in high MELD ‐ which is better?

We read with interest the study by Wong et al. (1) We congratulate the authors for the commendable work. We would like to share our concerns regarding the study. There were a greater number of patients with hepatorenal syndrome (HRS) in the deceased donor liver transplantation (DDLT) group than living donor liver transplantation (LDLT) group. (1) Presence of HRS, even in a low model for end-stage liver disease (MELD) patient, increases the risk of waitlist mortality which may be one of the reasons for higher waitlist mortality in the DDLT group.